Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |